Bayer (FRA:BAYN) Given a €70.00 Price Target at Deutsche Bank

Deutsche Bank set a €70.00 ($81.40) price target on Bayer (FRA:BAYN) in a research note released on Wednesday, Borsen Zeitung reports. The firm currently has a neutral rating on the healthcare company’s stock.

Several other research firms have also weighed in on BAYN. Sanford C. Bernstein set a €90.00 ($104.65) price objective on shares of Bayer and gave the stock a buy rating in a research note on Tuesday, July 30th. Goldman Sachs Group set a €77.00 ($89.53) price objective on shares of Bayer and gave the stock a buy rating in a research note on Tuesday, July 30th. Credit Suisse Group set a €70.00 ($81.40) price objective on shares of Bayer and gave the stock a buy rating in a research note on Thursday, July 4th. Baader Bank set a €123.00 ($143.02) price objective on shares of Bayer and gave the stock a buy rating in a research note on Tuesday, July 30th. Finally, JPMorgan Chase & Co. set a €70.00 ($81.40) price objective on shares of Bayer and gave the stock a neutral rating in a research note on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and twelve have issued a buy rating to the stock. Bayer presently has a consensus rating of Hold and a consensus price target of €80.61 ($93.73).

Shares of FRA:BAYN opened at €58.00 ($67.44) on Wednesday. Bayer has a one year low of €91.58 ($106.49) and a one year high of €123.82 ($143.98). The business’s 50 day simple moving average is €58.37.

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Recommended Story: Day Trading – Risk Worth the Reward?

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.